A yeast model for Aβ aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity.

Archive ouverte

d'Angelo, Fabien | Vignaud, Hélène | Di Martino, Julie | Salin, Bénédicte | Devin, Anne | Cullin, Christophe | Marchal, Christelle

Edité par CCSD ; Cambridge Company of Biologists -

International audience. Alzheimer's disease is the most common neurodegenerative disease, associated with aggregation of Aβ peptides. The exact mechanism of neuronal cell dysfunction in Alzheimer's disease is poorly understood and numerous models have been used to decipher the mechanisms leading to cellular death. Yeast cells might be a good model to understand the intracellular toxicity triggered by Aβ peptides. Indeed, yeast has been used as a model to examine protein functions or cellular pathways that mediate the secretion, aggregation, and subsequent toxicity of proteins associated with human neurodegenerative disorders. In the present study, we use the yeast Saccharomyces cerevisiae as a model system to study the effects of intracellular Aβ in fusion with the green fluorescent protein. We sent this fusion protein into the secretory pathway, and showed that intracellular traffic pathways are necessary to generate toxic species. Yeast PICALM orthologs are involved in cellular toxicity, indicating conservation of the mechanisms of toxicity from mammals to yeast. Finally, our model demonstrates the capacity for intracellular Aβ to cross intracellular membranes and target mitochondrial organelles.

Consulter en ligne

Suggestions

Du même auteur

ERAD defects and the HFE-H63D variant are associated with increased risk of liver damages in Alpha 1-Antitrypsin Deficiency

Archive ouverte | Joly, Philippe | CCSD

International audience

The Impact of ESCRT on Aβ1-42 Induced Membrane Lesions in a Yeast Model for Alzheimer’s Disease

Archive ouverte | Fruhmann, Gernot | CCSD

International audience. Aβ metabolism plays a pivotal role in Alzheimer's disease. Here, we used a yeast model to monitor Aβ 42 toxicity when entering the secretory pathway and demonstrate that processing in, and ex...

A structure-toxicity study of Aß42 reveals a new anti-parallel aggregation pathway.

Archive ouverte | Vignaud, Hélène | CCSD

International audience. Amyloid beta (Aβ) peptides produced by APP cleavage are central to the pathology of Alzheimer's disease. Despite widespread interest in this issue, the relationship between the auto-assembly ...

Chargement des enrichissements...